Template:Opioid receptor modulators: Difference between revisions

Jump to navigation Jump to search
(remove redirects)
 
imported>Paine Ellsworth
(convert to /doc page)
Line 12: Line 12:
* [[7-Hydroxymitragynine]]
* [[7-Hydroxymitragynine]]
* [[ψ-Akuammigine]]
* [[ψ-Akuammigine]]
* [[α-Chlornaltrexamine]]<!--Irreversible-->
* [[Chlornaltrexamine|α-Chlornaltrexamine]]<!--Irreversible-->
* [[alpha-Narcotine|α-Narcotine]]
* [[alpha-Narcotine|α-Narcotine]]
* [[Acetyldihydrocodeine]]
* [[Acetyldihydrocodeine]]
Line 24: Line 24:
* [[Anileridine]]
* [[Anileridine]]
* [[Apparicine]]
* [[Apparicine]]
* [[β-Endorphin]]
* [[Beta-Endorphin|β-Endorphin]]
* [[Bovine adrenal medullary peptide-12P|BAM-12P]]
* [[Bovine adrenal medullary peptide-12P|BAM-12P]]
* [[Bovine adrenal medullary peptide-18P|BAM-18P]]
* [[Bovine adrenal medullary peptide-18P|BAM-18P]]
Line 37: Line 37:
* [[Butorphanol]]
* [[Butorphanol]]
* [[Butyrfentanyl]]
* [[Butyrfentanyl]]
* [[BW-373U86]]
* [[BW373U86]]
* [[Carfentanil]]
* [[Carfentanil]]
* [[Casokefamide]]
* [[Casokefamide]]
Line 134: Line 134:
* [[Propiram]]
* [[Propiram]]
* [[PZM21]]
* [[PZM21]]
* [[Racemethorphan]]
* [[Methorphan|Racemethorphan]]
* [[Racemorphan]]
* [[Racemorphan]]
* [[Remifentanil]]
* [[Remifentanil]]
Line 171: Line 171:
* [[18-Methoxycoronaridine|18-MC]]
* [[18-Methoxycoronaridine|18-MC]]
* [[alpha-Gliadin|α-Gliadin]]
* [[alpha-Gliadin|α-Gliadin]]
* [[β-Chlornaltrexamine]]<!--Irreversible-->
* [[Chlornaltrexamine|β-Chlornaltrexamine]]<!--Irreversible-->
* [[beta-Funaltrexamine|β-Funaltrexamine]]<!--Irreversible-->
* [[beta-Funaltrexamine|β-Funaltrexamine]]<!--Irreversible-->
* [[Akuammine]]
* [[Akuammine]]
* [[Alvimopan]]
* [[Alvimopan]]
* [[AM251|AM-251]]
* [[AM-251 (drug)|AM-251]]
* [[Apigenin]]
* [[Apigenin]]
* [[AT-076]]
* [[AT-076]]
Line 181: Line 181:
* [[Bevenopran]]
* [[Bevenopran]]
* [[Catechin]]
* [[Catechin]]
* [[Catechin gallate]]
* [[Epicatechin gallate|Catechin gallate]]
* [[Clocinnamox]]<!--Irreversible-->
* [[Clocinnamox]]<!--Irreversible-->
* [[CTAP]]
* [[CTAP]]
Line 190: Line 190:
* [[Diprenorphine]]
* [[Diprenorphine]]
* [[Epicatechin gallate|ECG]]
* [[Epicatechin gallate|ECG]]
* [[Epigallocatechin|EGC]]
* [[gallocatechol|EGC]]
* [[Epicatechin]]
* [[Epicatechin]]
* [[Eptazocine]]
* [[Eptazocine]]
Line 245: Line 245:
* [[AR-M100390|AR-M100390 (ARM390)]]
* [[AR-M100390|AR-M100390 (ARM390)]]
* [[AZD2327]]
* [[AZD2327]]
* [[β-Endorphin]]
* [[Beta-Endorphin|β-Endorphin]]
* [[Bovine adrenal medullary peptide-18P|BAM-18P]]
* [[Bovine adrenal medullary peptide-18P|BAM-18P]]
* [[Biphalin]]
* [[Biphalin]]
Line 251: Line 251:
* [[Butorphan]]
* [[Butorphan]]
* [[Butorphanol]]
* [[Butorphanol]]
* [[BW-373U86]]
* [[BW373U86]]
* [[Casokefamide]]
* [[Casokefamide]]
* [[Cebranopadol]]
* [[Cebranopadol]]
Line 303: Line 303:
* [[Pethidine|Pethidine (meperidine)]]
* [[Pethidine|Pethidine (meperidine)]]
* [[Proglumide]]
* [[Proglumide]]
* [[Racemethorphan]]
* [[Methorphan|Racemethorphan]]
* [[Racemorphan]]
* [[Racemorphan]]
* [[RWJ-394674]]
* [[RWJ-394674]]
Line 313: Line 313:
* [[TH-030418]]
* [[TH-030418]]
* [[Thebaine]]
* [[Thebaine]]
* [[Thiobromadol|Thiobromadol (C-8813)]]
* [[C-8813|Thiobromadol (C-8813)]]
* [[Tonazocine]]
* [[Tonazocine]]
* [[Tramadol]]
* [[Tramadol]]
Line 325: Line 325:
* [[6β-Naltrexol-d4]]
* [[6β-Naltrexol-d4]]
* [[alpha-Santolol|α-Santolol]]
* [[alpha-Santolol|α-Santolol]]
* [[β-Chlornaltrexamine]]<!--Irreversible-->
* [[Chlornaltrexamine|β-Chlornaltrexamine]]<!--Irreversible-->
* [[Apigenin]]
* [[Apigenin]]
* [[AT-076]]
* [[AT-076]]
Line 332: Line 332:
* [[7-Benzylidenenaltrexone|BNTX]]<!--Selective δ1 antagonist-->
* [[7-Benzylidenenaltrexone|BNTX]]<!--Selective δ1 antagonist-->
* [[Catechin]]
* [[Catechin]]
* [[Catechin gallate]]
* [[Epicatechin gallate|Catechin gallate]]
* [[Clocinnamox]]
* [[Clocinnamox]]
* [[Diacetylnalorphine]]
* [[Diacetylnalorphine]]
* [[Diprenorphine]]
* [[Diprenorphine]]
* [[Epicatechin gallate|ECG]]
* [[Epicatechin gallate|ECG]]
* [[Epigallocatechin|EGC]]
* [[gallocatechol|EGC]]
* [[Eluxadoline]]
* [[Eluxadoline]]
* [[Epicatechin]]
* [[Epicatechin]]
Line 376: Line 376:
* [[18-Methoxycoronaridine|18-MC]]
* [[18-Methoxycoronaridine|18-MC]]
* [[14-Methoxymetopon]]
* [[14-Methoxymetopon]]
* [[β-Chlornaltrexamine]]
* [[Chlornaltrexamine|β-Chlornaltrexamine]]
* [[beta-Funaltrexamine|β-Funaltrexamine]]
* [[beta-Funaltrexamine|β-Funaltrexamine]]
* [[Adrenorphin|Adrenorphin (metorphamide)]]
* [[Adrenorphin|Adrenorphin (metorphamide)]]
Line 392: Line 392:
* [[Butorphan]]
* [[Butorphan]]
* [[Butorphanol]]
* [[Butorphanol]]
* [[BW-373U86]]
* [[BW373U86]]
* [[Cebranopadol]]
* [[Cebranopadol]]
* [[Ciprefadol]]
* [[Ciprefadol]]
Line 469: Line 469:
* [[Phenazocine]]
* [[Phenazocine]]
* [[Proxorphan]]
* [[Proxorphan]]
* [[Racemethorphan]]
* [[Methorphan|Racemethorphan]]
* [[Racemorphan]]
* [[Racemorphan]]
* [[RB-64]]<!--Biased agonist-->
* [[RB-64]]<!--Biased agonist-->
Line 481: Line 481:
* [[Tifluadom]]
* [[Tifluadom]]
* [[Tricyclic antidepressant]]s (e.g., [[amitriptyline]], [[desipramine]], [[imipramine]], [[nortriptyline]])
* [[Tricyclic antidepressant]]s (e.g., [[amitriptyline]], [[desipramine]], [[imipramine]], [[nortriptyline]])
* [[U-50,488]]
* [[U-50488]]
* [[U-54,494A]]
* [[U-54,494A]]
* [[U-69,593]]
* [[U-69,593]]
Line 492: Line 492:
* [[6β-Naltrexol]]
* [[6β-Naltrexol]]
* [[6β-Naltrexol-d4]]
* [[6β-Naltrexol-d4]]
* [[β-Chlornaltrexamine]]<!--Irreversible-->
* [[Chlornaltrexamine|β-Chlornaltrexamine]]<!--Irreversible-->
* [[Buprenorphine/samidorphan]]
* [[Buprenorphine/samidorphan]]
* [[Amentoflavone]]
* [[Amentoflavone]]
Line 505: Line 505:
* [[Buprenorphine]]
* [[Buprenorphine]]
* [[Catechin]]
* [[Catechin]]
* [[Catechin gallate]]
* [[Epicatechin gallate|Catechin gallate]]
* [[CERC-501|CERC-501 (LY-2456302)]]
* [[CERC-501|CERC-501 (LY-2456302)]]
* [[Clocinnamox]]
* [[Clocinnamox]]
Line 511: Line 511:
* [[Dezocine]]
* [[Dezocine]]
* [[DIPPA]]<!--Irreversible-->
* [[DIPPA]]<!--Irreversible-->
* [[Epigallocatechin|EGC]]
* [[gallocatechol|EGC]]
* [[Epicatechin gallate|ECG]]
* [[Epicatechin gallate|ECG]]
* [[Epicatechin]]
* [[Epicatechin]]
Line 573: Line 573:
* [[Nociceptin (1-13)NH2|Nociceptin (1-13)NH<sub>2</sub>]]
* [[Nociceptin (1-13)NH2|Nociceptin (1-13)NH<sub>2</sub>]]
* [[Norbuprenorphine]]
* [[Norbuprenorphine]]
* [[Racemethorphan]]
* [[Methorphan|Racemethorphan]]
* [[Racemorphan]]
* [[Racemorphan]]
* [[Ro64-6198]]
* [[Ro64-6198]]
Line 653: Line 653:


}}<noinclude>
}}<noinclude>
{{collapsible option}}
{{Documentation}}
[[Category:Drug templates by receptor, channel, or pump]]
</noinclude>
</noinclude>

Revision as of 01:49, 7 January 2019